Virginia Retirement Systems Et Al Global Blood Therapeutics, Inc. Transaction History

Virginia Retirement Systems Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $248,490 - $420,882	-6,600 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$52.76 - $74.49 $31,656 - $44,694	-600 Reduced 8.33%	6,600 $364,000
Q2 2020 Aug 12, 2020	BUY	$48.73 - $81.82 $9,746 - $16,363	200 Added 2.86%	7,200 $455,000
Q1 2020 May 12, 2020	SELL	$41.72 - $87.2 $8,344 - $17,440	-200 Reduced 2.78%	7,000 $358,000
Q4 2019 Jan 27, 2020	BUY	$45.7 - $81.86 $329,040 - $589,392	7,200 New	7,200 $572,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.